34 PRIMECAP Management Bristol-Myers Squibb Trades
PRIMECAP Management's position in Bristol-Myers Squibb is currently worth $1.07B. That's 0.78% of their equity portfolio (40th largest holding). The first Bristol-Myers Squibb trade was made in Q1 2017. Since then PRIMECAP Management bought shares fifteen more times and sold shares on eighteen occasions. The investor's estimated purchase price is $1.32B, resulting in a loss of 19%.
News about Bristol-Myers Squibb Co. and PRIMECAP Management
CIBC Asset Management Inc Sells 10,401 Shares of Bristol-Myers Squibb (NYSE:BMY)
CIBC Asset Management Inc reduced its stake in Bristol-Myers Squibb (NYSE:BMY ¨C Free Report) by 2.7% in the 3rd quarter, according to the company in its most...
Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript)
Bristol-Myers Squibb Company (NYSE:NYSE:BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference January 4, 2024 11:00 AM ETCompany ParticipantsAdam¡
Dechtman Wealth Management LLC Trims Holdings in Bristol-Myers Squibb (NYSE:BMY)
Dechtman Wealth Management LLC decreased its holdings in Bristol-Myers Squibb (NYSE:BMY ¨C Free Report) by 58.9% during the third quarter, according to the co...
Bristol-Myers Squibb Company (BMY) Management Presents at 2023 UBS BioPharma Conference (Transcript)
Bristol-Myers Squibb Company (NYSE:NYSE:BMY) 2023 UBS BioPharma Conference Transcript November 8, 2023 8:00 AM ETExecutivesLynelle Hoch - Head, Cell¡